Aloka Releases New Features, Functionality in High-Performance Digital
Ultrasound System
TOKYO, Nov. 24 /PRNewswire/ -- Aloka Co., Ltd. today introduced a new
version of its high-performance ProSound Alpha 10 ultrasound system. The
ProSound Alpha 10 new version 5 incorporates image enhancements and
features, such as Compound Pulse Wave Generator (CPWG), Broadband
Harmonics, Directional eFLOW and eTRACKING and Flow Mediated Dilatation
(FMD). The company's newest scanner is on exhibit at the Radiological
Society of North America (RSNA) from November 26-30, 2006 in Chicago, IL.
Superior Image Quality with Compound Pulse Wave Generator (CPWG) and
Broadband Harmonics New Version 5 of Aloka's Prosound Alpha 10 is equipped
with programmable CPWG. This technology provides optimum imaging through
precise delay control of the frequency and amplitude in each individual
ultrasound transmission. The system also features newly designed Compound
Impulse waveform which enables the system to transmit broader bandwidth
from Hemispheric Sound Technology Plus (HST+) transducers used to
differentiate anatomical structures in "hard to image" patients. This
revolutionary transmission capability works with Extended Pure Harmonics
Detection, an Aloka innovation that is standard on the company's premium
prosound product line.
These technologies combine to create what Aloka calls intelligent
Broadband Harmonics. Broadband Harmonics delivers higher sensitivity and
superior spatial resolution; there is no longer a trade-off between spatial
resolution and penetration.
Directional eFLOW
Broadband Harmonics also enhances a high-definition blood flow imaging
mode used primarily for vascular imaging: Directional eFLOW. Directional
eFLOW can be used for both low-velocity and high-velocity flow, delivering
greater spatial and temporal resolution.
eTRACKING and FMD for Preventative Medicine
Aloka's eTRACKING (Echo Tracking) is a new, more accurate way to
evaluate vessel wall stiffness before the onset of changes such as
thickening or plaque formation. eTRACKING allows you to detect
atherosclerosis much earlier than commonly used Intima Medial Thickness
(IMT). By estimating a patient's "blood vessel age", a healthcare provider
can advise the patient to alter his or her lifestyle through diet and
exercise to prevent atherosclerosis. eTRACKING also supports accurate
tracking of treatment at 0.01mm accuracy.
eTRACKING also enables FMD, a non-invasive way to assess endothelial
function, which is considered the first indicator of atherosclerosis. FMD
measures minute vasodilatation with 0.01mm accuracy.
Aloka at Booth 6521 at RSNA
Aloka executives and sales representative will be on hand at booth 6521
at RSNA to discuss the new features and benefits of the ProSound Alpha 10.
About Aloka
Aloka Company, Ltd. (TSE: 7704) -- The Innovator in Ultrasound -- has
proudly served the worldwide medical community for more than 50 years. As
one of the longest continuously operating ultrasound companies in the
world, Aloka is one of the most experienced and most innovative firms in
the diagnostic ultrasound market. One of the important innovations
introduced by Aloka in 1983 was color Doppler technology. Today, this
technique had become an indispensable diagnostic tool for many ultrasound
examinations in a wide variety of clinical applications. The company has
installed more than 187,000 ultrasound systems and has worldwide revenues
of approximately US$415 million. http://www.aloka.com
Contact (Japan):
Masanobu Tada
Phone: +81-422-45-9247
Aloka Company, Ltd.
E-mail: tada1486@am.aloka.co.jp
Contact (US):
Katie Lybrook
Aloka Company, Ltd.
Phone: +1-203-269-5088, ext. 206
E-mail: klybrook@aloka.com
SOURCE Aloka Company, Ltd.
 back to top
Related links:
http://www.aloka.com
CONTACT:
Japan: Masanobu Tada, +81-422-45-9247,
tada1486@am.aloka.co.jp, or US: Katie Lybrook, +1-203-269-5088,
ext. 206, klybrook@aloka.com, both of Aloka Company, Ltd.
|
